Cases 1 - 10 of 35
ZS Pharma, Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2023cv01190
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2023cv00665
Plaintiff:
Bayer Pharma AG, Janssen Pharmaceuticals, Inc. and Bayer AG
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2022cv01100
Counter Defendant:
ZS Pharma, Inc.
Plaintiff:
AstraZeneca Pharmaecuticals LP
Defendant:
Macleods Pharmaceuticals Ltd.
Counter Claimant:
Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. et al v. Macleods Pharmaceuticals Ltd. et al.
as 1:2021cv01350
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2021cv00316
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2020cv01180
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
